Implantable Magnetic Nanoparticle Biosensor for Real-Time In Vivo Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro biomarker detection methods lack the ability to provide local, real-time information on biomolecule concentrations in vivo, especially for predictive biomarkers in cancer treatment, and existing in vivo methods face technical, regulatory, and economic barriers.
Innovation Solution
An implantable biosensor using functionalized nanoparticles that change their magnetic response signal upon interaction with targeted biomolecules, allowing for quantitative in vivo measurements through AC magnetic spectroscopy, optimized for low-field and frequency readouts, and designed for minimally-invasive implantation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If colorimetric in vitro assay technology is used for biomarker detection, then measurement precision is improved, but the ability to provide local real-time in vivo information is lost
Solution Approach 1:
The patent replaces conventional optical colorimetric detection with magnetic field-based detection using functionalized magnetic nanoparticles. The magnetic nanoparticles serve as contrast agents that can be detected by MRI, enabling in vivo measurement while maintaining detection precision. This substitution allows the system to function within the magnetic field environment of the body without relying on optical systems that cannot penetrate tissue effectively.
Solution Approach 2:
The patent introduces functionalized magnetic nanoparticles as intermediaries between the target biomolecules and the detection system. These nanoparticles are coated with ligands that specifically bind to target molecules, and their magnetic properties enable detection by MRI. This intermediary approach allows indirect detection of biomarkers in vivo with high precision, bridging the gap between molecular-level interactions and macroscopic imaging capabilities.
2Measurement precision
If invasive tissue biopsies are performed to obtain local information, then local biomolecule concentration is measured, but only at a single time point and with invasive procedures
Solution Approach 1:
The patent enables continuous monitoring of biomarker concentrations over time through repeated MRI scans. The functionalized magnetic nanoparticles remain in the target tissue and can be detected repeatedly without requiring additional invasive procedures. This continuous detection capability transforms single-time-point measurements into longitudinal monitoring, allowing clinicians to track biomarker dynamics throughout treatment.
Solution Approach 2:
The magnetic nanoparticles automatically accumulate in the target tissue through passive targeting or active binding mechanisms, eliminating the need for repeated invasive administrations. Once injected, the nanoparticles perform the detection function continuously, serving themselves by remaining localized and maintaining their detection capability without external intervention.
3Loss of information
If functionalized magnetic contrast agents are used for in vivo imaging, then deep tissue data is obtained, but technical barriers related to half-life, biodistribution, and adverse events remain
Solution Approach 1:
The patent employs composite magnetic nanoparticle structures with multiple functional components: a magnetic core for MRI detection, a stabilizing shell for biocompatibility, and surface-bound ligands for target-specific binding. This composite structure optimizes multiple properties simultaneously - magnetic signal strength, circulation half-life, biodistribution, and target affinity - thereby improving reliability while maintaining deep tissue detection capability.
Solution Approach 2:
The patent systematically optimizes critical parameters including nanoparticle size (typically 10-100 nm), magnetic core composition (iron oxide variants), surface coating materials (PEG, proteins, polymers), and ligand density. By adjusting these parameters, the system achieves optimal balance between detection sensitivity, circulation time, tissue penetration, and biocompatibility, addressing safety and regulatory concerns while enabling reliable in vivo detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables accurate, real-time measurement of local biomolecule concentrations, facilitating informed treatment decisions by overcoming viscosity-independent Neel relaxation-based detection, reducing adverse reactions, and providing economical alternatives to MRI.
Implementation Method 1
overcoming viscosity-independent Neel relaxation-based detection
Implementation Method 2
functionalized nanoparticles that change their magnetic response signal upon interaction with targeted biomolecules
Data Source
AI summary
The system disclosed comprises an apparatus and a method for the detection and quantification of targeted molecules in vivo. The apparatus comprises an implantable biosensor and an AC magnetic detection device. The implantable biosensor includes functionalized nanoparticles functionalized with one or more moieties that bind to a molecular target of interest. The nanoparticles are retained in a biocompatible container which allows the molecular target of interest to enter the biosensor, for example through a semipermeable port. The biosensor can be implanted minimally-invasively into humans or animals. Upon exposure of the nanoparticles to the molecular target, a change in Neel relaxation time can be externally detected and correlated to the target analytes concentration. The change in relaxation time is detected through magnetic AC spectrometric measurements at a frequency specifically tuned to the nanoparticle type of interest Additionally, a method is provided for quantifying one or several biosensors within one specimen.